Lada Mitchell

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Stevo Julius, Sverre E. Kjeldsen, Michael A. Weber et al. · The Lancet · 2004 · 2.5K citations

Medicine, Pharmacology, Pharmacotherapy +13

Applied Multivariate Statistics for the Social Sciences

Lada Mitchell · Journal of the Royal Statistical Society Series D (The Statistician) · 2003 · 988 citations

Natural Sciences, Biostatistics, Statistics +8

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

Michael A. Weber, Stevo Julius, Sverre E. Kjeldsen et al. · The Lancet · 2004 · 592 citations

Medicine, Cardiology, Pharmacotherapy +11

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

Fabrice Barlési, Arnaud Scherpereel, Achim Rittmeyer et al. · Journal of Clinical Oncology · 2013 · 327 citations

Medicine, Oncology, Pharmacology +12

Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study

James Larkin, Michele Del Vecchio, Paolo A. Ascierto et al. · The Lancet Oncology · 2014 · 292 citations

Medicine, Oncology, Pharmacology +12